Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV-1 Env protein is crucial for viral entry, mediating attachment to host cells via gp120 binding to CD4 and a coreceptor (CCR5 or CXCR4), followed by gp41-mediated membrane fusion. It is initially synthesized as gp160, then cleaved into gp120 and gp41. The mature functional form is a trimer. Env is a major target for neutralizing antibodies and vaccine design but its high variability presents significant challenges.
Inhibition of viral entry by blocking gp120 binding to CD4 or coreceptors (CCR5/CXCR4), or by preventing gp41-mediated membrane fusion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Immunodeficiency Virus Type 1 Env Protein.